Is magnetic therapy effective for tinnitus?

September 18, 2012

Loyola University Medical Center is studying whether a new form of non-invasive magnetic therapy can help people who suffer debilitating tinnitus (ringing in the ears).

The therapy, transcranial (TMS), sends short pulses of magnetic fields to the brain. TMS has been approved since 2009 for who have and have failed at least one antidepressant.

The Loyola study will include patients who suffer from both depression and . Recent studies have found that about 12 percent of people with also suffer depression and anxiety—a rate three times higher than that of the general population.

Tinnitus is the perception of sound in one or both ears when there is no external source. It can include ringing, hissing, roaring, whistling, chirping or clicking. About 50 million Americans have at least some tinnitus; 16 million seek medical attention and about 2 million are seriously debilitated, according to the American Tinnitus Association. There is no cure.

The perception of phantom sounds can be more pronounced in people who are depressed. Moreover, antidepressant medications can cause tinnitus occasionally, said Dr. Murali Rao, principal investigator of Loyola's TMS tinnitus study.

Several earlier studies have found that TMS can benefit tinnitus patients. Loyola's study is the first to examine patients who suffer from both tinnitus and depression. "The combination of these two conditions can be extremely debilitating," Rao said.

During TMS treatment, the patient reclines in a comfortable padded chair. A magnetic coil, placed next to the left side of the head, sends short pulses of magnetic fields to the surface of the brain. This produces currents that stimulate . The currents, in turn, affect mood- deeper in the brain. The resulting changes in the brain appear to be beneficial to patients who suffer depression. Each treatment lasts 35 to 40 minutes.

The study will enroll 10 to 15 patients. Each patient will receive five treatments a week for four to six weeks, for a total of 20 to 30 treatments. Each patient will be evaluated by a physician three times during the treatment course, or more frequently if the doctor deems necessary.

The treatments do not require anesthesia or sedation. Afterward, a patient can immediately resume normal activities, including driving. Studies have found that patients do not experience memory loss or seizures. Side effects include mild headache or tingling in the scalp, which can be treated with Tylenol.

Rao is chair of the Department of Psychiatry and Behavioral Neurosciences of Loyola University Chicago Stritch School of Medicine. His co-investigator in the study is Sam Marzo, MD, medical director of Loyola's Balance and Hearing Center. Other investigators are Matthew Niedzwiecki, MD, a psychiatry resident; and James Sinacore, PhD, a statistician.

Explore further: Magnetic therapy becoming more popular for treating depression

Related Stories

Magnetic therapy becoming more popular for treating depression

February 6, 2012
(Medical Xpress) -- A new magnetic therapy that treats major depression recently received a major boost when the government announced Medicare will cover the procedure in Illinois.

Study: Insomnia takes toll on tinnitus patients

April 19, 2012
For the more than 36 million people plagued by tinnitus, insomnia can have a negative effect on the condition, worsening the functional and emotional toll of chronic ringing, buzzing, hissing or clicking in the head and ears, ...

Study provides compelling evidence for an effective new treatment for tinnitus

May 24, 2012
According to new research, a multidisciplinary approach to treating tinnitus that combines cognitive behaviour therapy with sound-based tinnitus retraining therapy is significantly more effective than currently available ...

Recommended for you

Groundbreaking investigative effort identifies gonorrhea vaccine candidates

September 19, 2017
Researchers at Oregon State University have identified a pair of proteins that show promise as the basis for a gonorrhea vaccine.

Snail fever progression linked to nitric oxide production

September 14, 2017
Bilharzia, caused by a parasitic worm found in freshwater called Schistosoma, infects around 200 million people globally and its advance can lead to death, especially in children in developing countries.

Systems analysis points to links between Toxoplasma infection and common brain diseases

September 13, 2017
More than 2 billion people - nearly one out of every three humans on earth, including about 60 million people in the United States - have a lifelong infection with the brain-dwelling parasite Toxoplasma gondii.

Study clears important hurdle toward developing an HIV vaccine

September 13, 2017
An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation ...

As 'flesh-eating' Leishmania come closer, a vaccine against them does, too

September 13, 2017
Parasites that ulcerate the skin, can disfigure the face, and may fatally mutilate its victim's internal organs are creeping closer to the southern edges of the United States.

Promising clinical trial results could give doctors a new tool against drug-resistant strains of malaria parasite

September 13, 2017
Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published in the latest issue of The Lancet Infectious ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.